Novolin r side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Novolin r (insulin recombinant purified human). Common side effects include blood glucose increased among females and blood glucose increased among males.
The phase IV clinical study is created by eHealthMe based on 4,529 reports from the FDA, and is updated regularly.
What is Novolin R?
Novolin r has active ingredients of insulin recombinant purified human. It is often used in type 1 diabetes. eHealthMe is studying from 4,568 Novolin r users. Check the latest studies of Novolin r.
4,529 people who take Novolin R and have side effects are studied.
What are the common side effects of Novolin r, by gender? *
What are the common side effects of Novolin r, by age (0-1 to 60+)? *
What are the common side effects of Novolin r, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Novolin r?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on insulin recombinant purified human (the active ingredients of Novolin r) and Novolin r (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Novolin r:
- Novolin r (4,568 reports)
All Novolin r side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Macitentan cause International Normalised Ratio Increased? - 3 seconds ago
- Could Neupogen cause Anorectal Abscess? - 4 seconds ago
- Could Fioricet cause Chronic Fatigue Syndrome? - 9 seconds ago
- Drug interactions of Rocuronium Bromide and Temaz - 21 seconds ago
- Could Inbrija cause Disease Progression? - 23 seconds ago
- Lung Neoplasm Malignant and Blood Creatinine Increased - 24 seconds ago
- Drug interactions of Patanol and Intal - 32 seconds ago
- Could Buspirone Hcl cause Inappropriate Affect? - 37 seconds ago
- Could Lipitor cause Intestinal Ischaemia? - 40 seconds ago
- Drug interactions of Xeljanz and Flaxseed - 48 seconds ago